4//SEC Filing
Rosenblum Mark J 4
Accession 0001615219-22-000141
CIK 0001615219other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 4:33 PM ET
Size
4.9 KB
Accession
0001615219-22-000141
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Common Stock
2022-11-03$1.73/sh+7,314$12,682→ 155,633 total
Footnotes (1)
- [F1]These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c).
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001329154
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 4:33 PM ET
- Size
- 4.9 KB